Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06744543 · ClinicalTrials.gov registry record · NA

Clinical Decision Support to Identify Pediatric Patients With Undiagnosed Genetic Disease

A NA study of Genetic Disease and Pediatrics, sponsored by Vanderbilt University Medical Center.

Active
Registry status
NA
Development phase
1,000
Enrollment target
1
Study location

NCT06744543 is a NA study of Genetic Disease and Pediatrics that is active but no longer recruiting, run by Vanderbilt University Medical Center. The registered enrollment target is 1,000 participants, below the 2,528-participant average among 30 other Genetic Disease trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06744543, a NA study of Genetic Disease and Pediatrics, is active but no longer recruiting, sponsored by Vanderbilt University Medical Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
1,000 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the effectiveness of SIGHT as a clinical support system to prompt provider/patient discussion and shared decision making regarding the need for genetic testing in the form of a chromosomal microarray. Identifying patients at high predicted probability of needing a test in clinical settings will be examined to determine if it decreases the duration of time to testing and increases diagnostic yield. SIGHT requires only data already collected in routine clinical encounters and is calculated prior to a clinical visit at VUMC.

Interventions

  • DEVICE SIGHT Prompted Provider Message

Study Locations (1)

Tennessee

  • Vanderbilt University Medical - Nashville

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2025-03-12
Est. Completion 2027-02-01
Phase NA

What the Registry Record Tells You About NCT06744543

The ClinicalTrials.gov registry entry for NCT06744543 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,528-participant average among 30 other Genetic Disease trials with a reported enrollment target (60% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Genetic Disease appearing as the primary indexed condition, and to 1 intervention - of which SIGHT Prompted Provider Message is the first listed.

NCT06744543 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT06744543 about?

NCT06744543 is a clinical study titled "Clinical Decision Support to Identify Pediatric Patients With Undiagnosed Genetic Disease". This study will evaluate the effectiveness of SIGHT as a clinical support system to prompt provider/patient discussion and shared decision making regarding the need for genetic testing in the form of a chromosomal microarray. Identifying patients at high predicted probability of needing a test in cl...

What is the current status of trial NCT06744543?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2025-03-12. Estimated completion is 2027-02-01.

What conditions does trial NCT06744543 study?

This clinical trial studies the following conditions: Genetic Disease, Pediatrics, Clinical Decision Support, Predictive Model.

What interventions are being tested in trial NCT06744543?

The interventions under investigation include: SIGHT Prompted Provider Message (DEVICE).

Who is sponsoring clinical trial NCT06744543?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06744543 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Genetic Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.